You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

ROGAINE EXTRA STRENGTH (FOR MEN) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Rogaine Extra Strength (for Men), and what generic alternatives are available?

Rogaine Extra Strength (for Men) is a drug marketed by Johnson And Johnson and is included in one NDA.

The generic ingredient in ROGAINE EXTRA STRENGTH (FOR MEN) is minoxidil. There are eight drug master file entries for this compound. One hundred and five suppliers are listed for this compound. Additional details are available on the minoxidil profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Rogaine Extra Strength (for Men)

A generic version of ROGAINE EXTRA STRENGTH (FOR MEN) was approved as minoxidil by WATSON LABS on March 3rd, 1987.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ROGAINE EXTRA STRENGTH (FOR MEN)?
  • What are the global sales for ROGAINE EXTRA STRENGTH (FOR MEN)?
  • What is Average Wholesale Price for ROGAINE EXTRA STRENGTH (FOR MEN)?
Summary for ROGAINE EXTRA STRENGTH (FOR MEN)
Drug patent expirations by year for ROGAINE EXTRA STRENGTH (FOR MEN)
Recent Clinical Trials for ROGAINE EXTRA STRENGTH (FOR MEN)

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ohio State University Comprehensive Cancer CenterEarly Phase 1
Cures Within ReachPhase 2
Loyola UniversityPhase 2

See all ROGAINE EXTRA STRENGTH (FOR MEN) clinical trials

Pharmacology for ROGAINE EXTRA STRENGTH (FOR MEN)
Drug ClassArteriolar Vasodilator
Physiological EffectArteriolar Vasodilation

US Patents and Regulatory Information for ROGAINE EXTRA STRENGTH (FOR MEN)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Johnson And Johnson ROGAINE EXTRA STRENGTH (FOR MEN) minoxidil SOLUTION;TOPICAL 020834-001 Nov 14, 1997 OTC Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

ROGAINE EXTRA STRENGTH (FOR MEN) Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Rogaine Extra Strength for Men

Introduction to Rogaine Extra Strength

Rogaine Extra Strength, formulated with 5% minoxidil, is a widely recognized treatment for male pattern baldness and hair thinning. This product is part of the broader minoxidil market, which has seen significant growth driven by several key factors.

Market Drivers

High Prevalence of Androgenetic Alopecia

The high prevalence of androgenetic alopecia (AGA), particularly among males aged 30-40, is a major driver of demand for Rogaine Extra Strength and other minoxidil products. AGA is a common condition that leads to significant hair loss, making treatments like Rogaine highly sought after[3][4].

Pharmaceutical Innovations

Continuous pharmaceutical innovations have enhanced the understanding and clinical efficacy of minoxidil. These advancements have led to the development of new topical medications, further boosting the market presence of Rogaine Extra Strength[3].

Marketing and Advertising

Intensive marketing and advertising efforts by brands like Rogaine have significantly increased consumer awareness and driven demand. Both online and traditional media campaigns have played a crucial role in the market's growth[3].

Lifestyle Changes and Economic Factors

Changes in lifestyle, increased disposable income, and a growing awareness of hair-related issues have contributed to the market's expansion. Regions like North America and Europe, with robust healthcare infrastructures and heightened awareness of hair loss, are particularly significant[3][4].

Product Overview: Rogaine Extra Strength

Formulations and Usage

Rogaine Extra Strength is available as a 5% minoxidil solution, which is branded as "Extra Strength" due to its potential for higher irritation risk compared to the foam formulation. Both the solution and foam are clinically proven to regrow hair in 3-6 months with consistent use[1][5].

Application and Results

The product is applied directly to the scalp twice daily, with results typically visible after 4-6 months. Initial shedding may occur as older, thinner hair makes way for new growth. Continued use is essential to maintain hair regrowth[2][5].

Market Segmentation

Regional Analysis

  • North America: This region is expected to hold the largest share of the global minoxidil market, driven by a robust healthcare infrastructure and high consumer awareness of hair loss treatments[3][4].
  • Europe: Europe is anticipated to show rapid growth due to substantial clinical studies and favorable market conditions. It is expected to grow at the fastest CAGR during the forecast period[3][4].
  • Asia-Pacific: Rapid urbanization and changing lifestyles in countries like China and India have propelled the demand for hair care products, including those containing minoxidil[3].
  • Middle East and Africa: This region presents a unique market landscape influenced by economic conditions, cultural attitudes, and regulatory frameworks[3].

Financial Trajectory

Market Size and Growth

The global minoxidil market, which includes Rogaine Extra Strength, is projected to reach significant financial milestones:

  • By 2030, the market is estimated to reach $1,637.7 million, growing at a CAGR of 5.2% from 2023 to 2030[3].
  • Alternatively, the market size is anticipated to exceed $1.89 billion by 2033, growing at a CAGR of 4.65% from 2023 to 2033[4].

Regional Revenue Streams

North America is expected to hold the largest share of the global minoxidil market, followed by Europe, which is also expected to show rapid growth due to favorable market conditions and extensive clinical studies[3][4].

Challenges and Limitations

Gradual Results and Maintenance

Minoxidil treatments, including Rogaine Extra Strength, require consistent use over several months to see noticeable results. Discontinuing use can lead to a reversal of any hair growth achieved[2][3].

Limited Effectiveness

While Rogaine Extra Strength is clinically proven to regrow hair, individual results can vary. Some users may not see the desired results, and the product may not be effective for everyone[2].

Consumer Awareness and Demand

Impact of Marketing

The incessant advertising by brands like Rogaine has heightened consumer awareness and driven demand for hair growth medications. This increased visibility has been crucial in boosting the prospects of the minoxidil market[3].

Lifestyle and Economic Factors

Changes in lifestyle and increased disposable income have contributed significantly to the market's expansion. Consumers are more aware of hair-related issues and are willing to invest in effective treatments like Rogaine Extra Strength[3][4].

Key Takeaways

  • The global minoxidil market, driven by the high prevalence of AGA, pharmaceutical innovations, and lifestyle changes, is expected to grow significantly.
  • Rogaine Extra Strength, with its 5% minoxidil solution, is a key player in this market, offering clinically proven hair regrowth.
  • The market is segmented regionally, with North America and Europe being the most significant regions.
  • Despite challenges like gradual results and limited effectiveness, the market holds promise with opportunities for growth and innovation.
  • The financial trajectory indicates a substantial increase in market size, reaching $1,637.7 million by 2030 or $1.89 billion by 2033.

FAQs

What is the projected market size of the global minoxidil market by 2030?

The global minoxidil market is estimated to reach $1,637.7 million by 2030[3].

What is the CAGR of the global minoxidil market from 2023 to 2033?

The market is expected to grow at a CAGR of 4.65% from 2023 to 2033[4].

Which region is expected to hold the largest share in the global minoxidil market?

North America is expected to hold the largest share of the global minoxidil market[3][4].

How does Rogaine Extra Strength work?

Rogaine Extra Strength works by boosting hair follicle activity and hair protein production, helping to maintain hair density and regrow hair. It penetrates the scalp to reactivate shrunken hair follicles[5].

What are the potential side effects of using Rogaine Extra Strength?

Potential side effects include chest pain, lightheadedness, increased or rapid heartbeat, difficulty breathing, swelling of the face or joints, and weight gain. Users should consult a healthcare professional if they experience any of these side effects[1].

Sources

  1. Hims, Rogaine Extra Strength vs Regular: What's The Difference, https://www.hims.com/blog/rogaine-extra-strength-vs-regular
  2. Rogaine, ROGAINE® Minoxidil Hair Regrowth Treatment for Thinning Hair, https://www.rogaine.com
  3. Drug Patent Watch, Generic MINOXIDIL INN equivalents, pharmaceutical patent expiry, https://www.drugpatentwatch.com/p/generic-api/minoxidil
  4. Business Research Insights, Minoxidil Market Size, Share, Trends | Forecast Report 2032, https://www.businessresearchinsights.com/market-reports/minoxidil-market-112286
  5. Mariano’s, Rogaine® Men's Extra Strength 5% Minoxidil Unscented Topical Hair Growth Solution, https://www.marianos.com/p/rogaine-men-s-extra-strength-5-minoxidil-unscented-topical-hair-growth-solution/0031254770020

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.